GPR18 in microglia: Implications for the CNS and endocannabinoid system signalling

British Journal of Pharmacology

Volumn 167, Issue 8, 2012, Pages 1575-1582

  McHugh, D ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

abnormal cannabidiol receptor; endocannabinoid; GPR18; microglia; NAGly

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; PROTEIN GPR18; RIMONABANT; UNCLASSIFIED DRUG;

CELL INTERACTION; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; GENETIC TRANSFECTION; GLIA; HUMAN; MICROARRAY ANALYSIS; MICROGLIA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; GLYCINE; HUMANS; MICROGLIA; NEURONS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84870575111     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02019.x     Document Type: Review

References (54)

1. Alexander S, (2012). So what do we call GPR18 now? Br J Pharmacol 165: 2411-2413.
2. Ballesteros J, Weistein H, (1995). Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G-protein-coupled receptors. Methods Neurosci 25: 366-428.
3. Baptiste DC, Powel KJ, Jollimore CAB, Hamilton C, LeVatte TL, Archibald ML, et al,. (2005). Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience 134: 575-582.
4. Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Mo FM, et al,. (2005). Evidence for novel cannabinoid receptors. Pharmacol Ther 106: 133-145.
5. Berman NE, Marcario JK, Yong C, Raghavan R, Raymond LA, Joag SV, et al,. (1999). Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes. Neurobiol Dis 6: 486-498.
6. Blasi E, Barluzzi R, Bocchini V, Mazzola R, Bistoni F, (1990). Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27: 229-237.
7. Bockaert J, Pin PJ, (1999). Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18: 1723-1729.
8. Bradshaw HB, Rimmerman N, Hu SS-J, Burstein S, Walker JM, (2009). Novel endogenous N-acyl glycines: identification and characterization. Vitam Horm 81: 191-205.
9. Burstein SH, McQuian CA, Ross AH, Salmonsen RA, Zurier RE, (2011). Resolution of inflammation by N-arachidonoylglycine. J Cell Biochem 112: 3227-3233.
10. Czigner A, Mihaly A, Farkas O, Buki A, Krisztin-Peva B, Dobo E, et al,. (2007). Kinetics of the cellular immune response following closed head injury. Acta Neurochir 149: 281-289.
11. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, et al,. (2007). Proliferating resident microglia after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 27: 1941-1953.
12. Devane WA, (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 252: 1946-1949.
13. Ferrer I, Bernet E, Soriano E, del Rio T, Fonseca M, (1990). Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience 39: 451-458.
14. Flaris NA, Hickey WF, (1992). Development and characterization of an experimental model of brain abscess in the rat. Am J Pathol 141: 1299-1307.
15. Franklin A, Stella N, (2003). Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol- sensitive receptors. Eur J Pharmacol 474: 195-198.
16. Games D, Buttini M, Kobayashi D, Schenk D, Seubert P, (2006). Mice as models: transgenic approaches and Alzheimer's disease. J Alzheimers Dis 9: 133-149.
17. Gantz I, Muraoka A, Yang Y-K, Samuelson LC, Zimmerman EM, Cook H, et al,. (1997). Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis. Genomics 42: 462-466.
18. Giuliani F, Hader W, Yong VW, (2005). Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol 78: 135-143.
19. Gowing G, Vallieres L, Julien JP, (2006). Mouse model for ablation of proliferating microglia in acute CNS injuries. Glia 53: 331-337.
20. Graeber MB, Streit WJ, Kreutzberg GW, (1988a). Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res 21: 18-24.
21. Graeber MB, Tetzlaff W, Streit WJ, Kreutzberg GW, (1988b). Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett 85: 317-321.
22. Horn F, Weare J, Beukers MW, Hörsch S, Bairoch A, Chen W, et al,. (1998). GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res 26: 275-179.
23. Huang SM, Bisogno T, Petros TJ, Chang SY, Zavitsanos PA, Zipkin RE, et al,. (2001). Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem 276: 42639-42644.
24. Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, et al,. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A 96: 14136-14141.
25. 9-tetrahydrocannabinol in BV-2 microglia. Br J Pharmacol 165: 2512-2528.
26. Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, et al,. (2006). Identification of N-arachidonoylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347: 827-832.
27. Konno H, Yamamoto T, Iwasaki Y, Suzuki H, Saito T, Terunuma H, (1989). Wallerian degeneration induces Ia-antigen expression in the rat brain. J Neuroimmunol 25: 151-159.
28. Lorton D, Schaller J, Lala A, De Nardin E, (2000). Chemotactic-like receptors and Aβ peptide induced responses in Alzheimer's disease. Neurobiol Aging 21: 463-473.
29. McHugh D, Hu SS-J, Rimmerman N, Juknat A, Vogel Z, Walker JM, et al,. (2010). N-Arachidonoyl glycine potently drives directed BV-2 microglial migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 11: 44.
30. McHugh D, Page J, Bradshaw H, (2011). siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates the cell migration induced by N-arachidonoyl glycine. The 21st Annual Symposium of the International Cannabinoid Research Society 2011: 2-3.
31. 9- Tetrahydrocannabinol and N-arachidonoyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol 165: 2414-2424.
32. Mackie K, Stella N, (2006). Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 8: E298-E306.
33. Maier K, Merkler D, Gerber J, Taheri N, Kuhnert AV, Williams SK, et al,. (2007). Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation. Neurobiol Dis 25: 514-525.
34. Mo FM, Offertáler L, Kunos G, (2004). Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur J Pharmacol 489: 21-27.
35. Morioka T, Baba T, Black KL, Streit WJ, (1992). Response of microglial cells to experimental rat glioma. Glia 6: 75-79.
36. Offertáler L, Mo F-M, Batkai S, Liu J, Begg M, Razdan RK, et al,. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63: 699-705.
37. Peri F, Nusslein-Volhard C, (2008). Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell 133: 916-927.
38. Pertwee RG, Ross RA, (2002). Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66: 101-121.
39. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, et al,. (2010). International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62: 588-631.
40. Qin Y, Verdegaal EME, Siderius M, Bebelman JP, Smit MJ, Leurs R, et al,. (2010). Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target. Pigment Cell Melanoma Res 24: 207-218.
41. Rao K, Lund RD, (1989). Degeneration of optic axons induces the expression of major histocompatibility antigens. Brain Res 488: 332-335.
42. Rezaie P, Lantos PL, (2001). Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Rev 35: 55-72.
43. Rosenkilde MM, Benned-Jensen T, Andersen H, Holst PJ, Kledal TN, Lüttichau HR, et al,. (2006). Molecular phenotyping of EBI2 an orphan seven-transmembrane receptor with constitutive activity. J Biol Chem 281: 13199-13208.
44. + channels for lysophosphatidic acid-induced microglial migration. Eur J Neurosci 19: 1469-1474.
45. Schlicker E, Kathmann M, (2001). Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22: 565-572.
46. Segal BM, (2003). Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr Allergy Asthma Rep 3: 86-93.
47. Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R, (1997). Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem 40: 659-667.
48. Takenouchi R, Inoue K, Kambe Y, Miyata A, (2012). N-arachidonoyl glycine induces macrophage apoptosis via GPR18. Biochem Biophys Res Commun 418: 366-371.
49. Vaccani A, Massi P, Colombo A, Rubino T, Palolaro D, (2005). Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 144: 1032-1036.
50. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, et al,. (2003). The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 100: 4903-4908.
51. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J, (2009). Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29: 3974-3980.
52. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, et al,. (2003). Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23: 1398-1405.
53. Yasuda Y, Shinagawa R, Yamada M, Mori T, Tateishi N, Fujita S, (2007). Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res 1138: 196-202.
54. Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, et al,. (2009). Lipid G protein-coupled receptor ligand identification using β-arrestin PathHunter⢠assay. J Biol Chem 284: 12328-12338.